Renaissance Technologies
AKCA

Renaissance Technologies’s Akcea Therapeutics Inc AKCA Stock Holding History

Renaissance Technologies’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-274,404
Closed -$4.98M – 3879
2020
Q3 		$4.98M Sell
274,404
-26,100
-9% -$370K 0.01% 1575
2020
Q2 		$4.12M Buy
300,504
+266,104
+774% +$4.11M ﹤0.01% 1761
2020
Q1 		$492K Sell
34,400
-35,800
-51% -$588K ﹤0.01% 2763
2019
Q4 		$1.19M Buy
+70,200
New +$1.31M ﹤0.01% 2550
2019
Q3 		– Sell
-19,200
Closed -$450K – 3842
2019
Q2 		$450K Buy
+19,200
New +$474K ﹤0.01% 3036

Renaissance Technologies's AKCA Position: Q4 2020 in Review

Renaissance Technologies sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 274,404 shares — an estimated $4.98M sold.

Renaissance Technologies first reported a position in AKCA in Q2 2019 and held it in 5 quarters. The position peaked at $4.98M in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Renaissance Technologies reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Renaissance Technologies sold 274,404 Akcea Therapeutics Inc shares in Q4 2020, an estimated $4.98M.
  • Renaissance Technologies first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 5 quarters.
  • Renaissance Technologies's Akcea Therapeutics Inc position peaked at $4.98M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.